Table 2.
Results of one-way PERMANOVA to detect differences in fecal community structure between pre-treatment (Pre), immediately post-treatment (Post), and four weeks post-treatment (4w post) samples collected from C57BL/6 J mice receiving the indicated treatments (n = 12)
| Treatment | Similarity | Main effects | Pre vs post | Pre vs 4w post | |||
|---|---|---|---|---|---|---|---|
| p | F | p | F | p | F | ||
| TMS | Bray–Curtis | 0.04 | 3.15 | 0.11 | 2.49 | 0.25 | 1.35 |
| Jaccard | 0.0001 | 4.90 | 0.02 | 2.02 | 0.0001 | 5.67 | |
| Enrofloxacin PO | Bray–Curtis | 0.0313 | 2.89 | 0.03 | 3.76 | 0.16 | 1.80 |
| Jaccard | 0.0001 | 6.81 | 0.0001 | 11.12 | 0.0001 | 5.48 | |
| Enrofloxacin IP | Bray–Curtis | 0.1334 | 1.80 | 0.20 | 1.61 | 0.45 | 0.75 |
| Jaccard | 0.0001 | 8.01 | 0.0001 | 7.32 | 0.0001 | 5.68 | |
| TAB | Bray–Curtis | 0.0001 | 9.58 | 0.0001 | 13.01 | 0.0007 | 11.56 |
| Jaccard | 0.0001 | 11.31 | 0.0001 | 15.83 | 0.0001 | 14.70 | |
| Control | Bray–Curtis | 0.0122 | 3.94 | 0.052 | 3.54 | 0.28 | 1.22 |
| Jaccard | 0.0001 | 6.34 | 0.0031 | 2.44 | 0.0001 | 6.67 | |